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Abstract—During myocardial reperfusion, polymorphonuclear neutrophil (PMN) adhesion involving the intercellular
adhesion molecule-1 (ICAM-1) may lead to aggravation and prolongation of reperfusion injury. We studied the role of
early tumor necrosis factor-a (TNF-a) cleavage and nuclear factor-kB (NF-kB) activation on ICAM-1 expression and
venular adhesion of PMN in isolated hearts after ischemia (15 minutes) and reperfusion (30 to 480 minutes). NF-kB
activation (electromobility shift assay) was found after 30 minutes of reperfusion and up to 240 minutes. ICAM-1
mRNA, assessed by Northern blot, increased during the same interval. Functional effect of newly synthesized adhesion
molecules was found by quantification (in situ fluorescence microscopy) of PMN, given as bolus after ischemia, which
became adherent to small coronary venules (10 to 50 mm in diameter). After 480 minutes of reperfusion,
ICAM-1–dependent PMN adhesion increased 2.5-fold compared with PMN adhesion obtained during acute reperfusion.
To study the influence of NF-kB on PMN adhesion, we inhibited NF-kB activation by transfection of NF-kB decoy
oligonucleotides into isolated hearts using HJV-liposomes. Decoy NF-kB but not control oligonucleotides blocked
ICAM-1 upregulation and inhibited the subacute increase in PMN adhesion. Similar effects were obtained using BB
1101 (10 mg), an inhibitor of TNF-a cleavage enzyme. These data suggest that ischemia and reperfusion in isolated
hearts cause liberation of TNF-a, activation of NF-kB, and upregulation of ICAM-1, an adhesion molecule involved in
inflammatory response after ischemia and reperfusion. (Circ Res. 1999;84:392-400.)
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Although reperfusion of an occluded coronary artery isstandard therapy to prevent myocardial necrosis,
tissue damage may be induced by reperfusion itself.
Numerous observations have confirmed a role of leuko-
cytes, specifically polymorphonuclear neutrophils
(PMNs), in mediating functional damage to endothelial
and myocardial cells during acute and late reperfusion.1–3
To exert this detrimental role, PMNs must interact with the
vascular wall, eg, by adherence to the postcapillary coro-
nary venules. In a well-established 2-step model of PMN
adhesion, PMNs are first decelerated by interaction of
selectins with their ligands, whereas leukocyte b2 integrins
and endothelial intercellular adhesion molecules
(ICAMs-1 to -3) provide firm adhesion.4,5
Leukocyte adhesion may be caused by acute endothelial
activation, which takes place within seconds through
translocation of stored P-selectin6 and release of proadhe-
sive mediators like platelet-activating factor.7,8 Later, with
these acute trigger mechanisms fading, leukocyte recruit-
ment is still observed. Subacute leukocyte adhesion, re-
quiring hours for its occurrence, is thought to rely on
distinct processes, most prominently altered protein ex-
pression. More generally, reperfusion induces a functional
change from a usually antiadhesive and anticoagulant
endothelium toward a proadhesive9 and procoagulatory10
cell lining, a process that fits the concept of subacute
endothelial activation.11
De novo synthesis of adhesion molecules like ICAM-112,13
provides functionally active protein within hours after the
onset of reperfusion. Therapeutic strategies aimed at inter-
rupting leukocyte binding to these receptors appear to protect
from subacute, leukocyte-dependent tissue damage, if cover-
ing the appropriate time window. In contrast, therapeutic
interventions limited to the acute reperfusion phase and
thereby neglecting subacute endothelial activation suffer loss
of cardioprotection over time.14,15 These findings indicate that
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subacute endothelial activation is an independent risk factor
for reperfusion injury of the heart.
The driving force of subacute endothelial activation seems
to be enhanced formation of proinflammatory and procoagu-
latory proteins, mediated by activation of transcription fac-
tors, eg, nuclear factor-kB (NF-kB). A well-characterized
activation cascade of NF-kB includes proteolysis of its
cytosolic inhibitor IkBa by the IkB kinase IKK.16 Thereafter,
nuclear localization of NF-kB and transactivation of promot-
ers containing the appropriate binding sequence, eg, ICAM-
117,18 come into effect. NF-kB activation can occur after
ischemia and reperfusion of the heart, as shown in a study by
Chandrasekar and Freeman.19
In the context of myocardial reperfusion injury, 3 questions
prompted us to characterize the postischemic subacute endo-
thelial activation more fully. First, does NF-kB activation
induce changes in transcription of ICAM-1, a gene with an
NF-kB binding promoter? For this purpose, hearts were
subjected to increasing intervals of reperfusion after ische-
mia, with tissue NF-kB activation as well as ICAM-1
expression being analyzed. Because recent findings suggest
that transfection of short oligonucleotides containing NF-kB
DNA binding sequence (decoy oligonucleotides) inhibits
NF-kB–dependent transcription (for review, see Reference
20), we used transfection of NF-kB decoy oligonucleotides to
demonstrate a causal relation of both processes. Second, does
enhanced transcription (and translation) of ICAM-1 lead to
enhanced PMN adhesion in coronary venules? Fluorescence
microscopy of rhodamine-labeled PMN was performed
acutely as well as subacutely, in the absence or presence of
NF-kB blocking interventions. Third, may rapid release of
TNF-a, a cytokine found in reperfused myocardium,21 con-
tribute to the transcriptional activation of ICAM-1? To
address this question, BB 1101, an inhibitor of a TNF-a
cleavage enzyme (TACE),22 was applied.
Materials and Methods
p50, p65, and IkBa antibodies were purchased from Santa Cruz.
dIdC was purchased from Pharmacia. Polyacrylamide was obtained
from Biozym. Hybond N and Hybond enhanced chemiluminescence
(ECL) membranes (Amersham) were used for Northern blotting and
Western blotting, respectively. All chemicals were purchased from
Sigma, if not indicated otherwise. Oligonucleotides were obtained
from MWG. BB 1101 was kindly provided by British Biotech
(Oxford, UK). ICAM-1 full-length cDNA was provided by Dr
Horiuchi (Daiichi Pharmaceuticals, Tokyo, Japan).
Heart Preparation
The care of the animals and all experimental procedures conform
with the Guide for the Care and Use of Laboratory Animals. Hearts
were isolated and perfused as previously described. Briefly, animals
(male, 250 to 350 g) were anesthetized (saturated ether) and
decapitated. The aorta was quickly cannulated, and hearts were
retrogradely perfused with a modified Krebs-Henseleit buffer gassed
with 94.5% O2/5.5% CO2 (37°C, pH 7.4060.05).
The working heart preparation was established as previously
described.8 The caval and azygos veins were ligated. Pulmonary
venous entry was used for a cannula that, in the working mode of the
heart, provided orthograde access for the perfusate. In the perfusion
apparatus, it was possible to switch between nonworking (Langen-
dorff) mode and working heart mode. External heart work was
calculated as the sum of pressure-volume work (developed aortic
pressure3cardiac output) and acceleration work.
Experimental Protocols
In experiments assessing external heart work, rat hearts performed
pressure volume work (preload 12 cm H2O, afterload 80 mm Hg) for
20 minutes. Hearts displaying a cardiac output under 35 mL/min
were excluded from the study. Thereafter, global ischemia (15
minutes, 37°C) was imposed. After ischemia, hearts were initially
reperfused in the nonworking Langendorff mode (5 mL/min, 15
minutes) before a second period of external heart work at the given
conditions was performed to assess acute reperfusion injury (myo-
cardial stunning). Application of the TACE inhibitor BB 1101 was
performed for 240 minutes of reperfusion or until the end of the
shorter experiments. Oligonucleotide transfection using HVJ-
liposomes was performed 10 minutes before ischemia and lasted 5
minutes. Immediately at the end of the experiment hearts, were
snap-frozen in liquid nitrogen and stored at 280°C. Three hearts per
group were analyzed, if not indicated otherwise.
In experiments assessing PMN adhesion by in situ fluorescence
microscopy, hearts and PMNs of guinea pigs were used, as previ-
ously established.23 After Langendorff preparation, hearts were
subjected to ischemia, various intervals of reperfusion, and a second
trigger of ischemia (15 minutes). Then, a PMN bolus (107 homolo-
gous cells, prestained with rhodamine 6G, diluted in 1 mL of
Tyrode’s solution) was infused 1 minute after the onset of reperfu-
sion, bringing the final concentration to 1666 PMN/mL. In one
experimental group, a monoclonal CD18 antibody (10 mg/mL MCA
503, Serotec) was added to the PMN for 10 minutes before injection.
After washout of nonadherent PMN (3 minutes), hearts were
arrested by cold cardioplegia (potassium 28 mmol/L) and placed on
a microscopic stage, the surface of the left ventricle being exposed to
a microscope (Ploemopak, Leitz) with a 310 objective (L10, 0.22
aperture, Leitz). Images were generated by a charge-coupled device
camera (COHU 4400, Prospective Measurements). To analyze vessel
distribution, fluorescein isothiocyanate dextran (FITC 0.1%, Mr
150 000) was infused (15 mL/h) and excited by epi-illumination with
an H130 mercury light source and filtered with an I2,3 filter block
(Leitz). The distribution of rhodamine 6G prestained PMNs was
studied under a rhodamine 6G selective N2 filter block (Leitz).
This method allowed for localization of PMNs with respect to the
vascular lumen. Postcapillary venular adhesion was observed in
venules of 10 to 50 mm in diameter (small venules; n518 to 25 per
heart).
ELISA Measurements (TNF-a and Interleukin-1)
Coronary effluent and transudate (interstitial/lymphatic fluid appear-
ing on the epicardial surface) of hearts undergoing ischemia and
reperfusion were collected at preischemic and postischemic time
points. Fluid samples were frozen on liquid nitrogen and stored at
280°C for ,8 weeks. Two different ELISA kits were used to detect
TNF-a (Endogen and Laboserv). Interleukin-1 (IL-1) was also
assessed with ELISA (Endogen). Because cytokine levels in the
coronary effluent were consistently below the detection limit ('5
pg/mL; data not shown), we only report coronary transudate levels.
Electrophoretic Mobility Shift Assay (EMSA)
Left ventricular tissue (200 mg) was lysed in a reducing Triton lysis
buffer (Tris 1 mmol/L (pH 7.4), NaCl 50 mmol/L, Triton 13, Na
vanadate 5 mmol/L, Na fluoride 50 mmol/L, Na pyrophosphate
30 mmol/L, DTT 1 mmol/L, PMSF 1 mmol/L, leupeptin 10 mmol/L,
and pepstatin 10 mmol/L). Separation of cytosolic and nuclear
protein lysates was achieved by 5-second centrifugation (10 000g),
according to the protocol of Schreck and Baeuerle.24 The membrane
fraction was separated by 15 minutes of centrifugation at 10 000g
(4°C) in both cases. Protein concentration of the lysates was
measured with a detergent-compatible assay (BCA, Pierce). Ten
micrograms of protein from lysates was incubated with dIdC (1 mg)
in binding buffer (10 mmol/L Tris [pH 7.5], 50 mmol/L NaCl,
0.5 mmol/L EDTA, 1 mmol/L DTT, 0.05 mmol/L PMSF, 2%/
volume glycerol, and 2% Ficoll 400) for 20 minutes. Thereafter,
lysates were exposed for 15 minutes to double-stranded oligonucle-
otides encoding an NF-kB consensus binding site (59-AGT TGA
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GGG GAC TTT CCC AGG C-39 and 59-GCC TGG GAA AGT CCC
CTC AAC T-39) or a nonbinding oligonucleotide (59-TTG CCG
TAC CTG ACT TAG CC-39 and 59-GGC TAA GTC AGG TAC
GGC AA-39) labeled with [32P] ATP using polynucleotide kinase
(Boehringer-Mannheim). Two microliters of p50 antibody (Santa
Cruz) or 7 mL of p65 antibody (Santa Cruz) were used for supershift
or deletion of specific bands. Protein-oligonucleotide mixtures were
separated on a 6% polyacrylamide gel. Finally, gels were dried and
exposed to x-ray film.
Northern Blot Analysis
To analyze mRNA induction, 200 mg of heart tissue were lysed with
guanidine-isothiocyanate/phenol. Phase separation was achieved
with 20% chloroform and centrifugation (12 000g, 15 minutes, 4°C).
Total RNA was precipitated by addition of 2-propanol (20 minutes,
room temperature), and the precipitate was centrifuged at 12 000g.
After removal of 2-propanol, the pellet was washed with 1 mL of
75% ethanol, centrifuged at 7000g, air-dried for 15 minutes, and
quantified in Tris-EDTA at 260 nm.
Aliquots (10 mg) of total RNA were separated on a 1% agarose gel
containing 5% formaldehyde and 13 MOPS. Overnight transfer was
performed using Hybond N filters, which thereafter were cross-
linked by UV light, prehybridized in salmon sperm DNA (50 mg),
and hybridized in 53 SSC, 0.5% SDS, and 13 Denhardt’s solution
for 12 hours using cDNA specific for the indicated gene, which was
32P labeled using random primers (Prime It II, Stratagene). After
washing in 43 SSC, 0.5% SDS, 13 Denhardt’s for 30 minutes, and
23 SSC, 0.5% SDS for 15 minutes 2 times, filters were exposed to
x-ray film.
Hybridization probes were used as full-length cDNA for ICAM-1
or obtained from rat mRNA that was reversely transcribed to cDNA.
The following primers were used to isolate the corresponding cDNA:
TNF-a, 59-CTC TTC TGT CTA CTG AAC TTC GG-39 and
59-AGA TAG CAA ATC GGC TGA CGG-39; IL-1, 59-CAC AGC
AGC ACA TCA ACA AGA GC-39 and 59-GTC CTG CTT GTG
AGG TGC TGA TG-39.
Western Blot Analysis
Protein lysates (40 mg) were separated on a 12% polyacrylamide gel,
transferred to a nitrocellulose membrane (Hybond ECL, Amersham),
blocked with buffer containing 5% nonfat dry milk, incubated with
2 mg/mL primary antibody (IkBa and p65, Santa Cruz), washed 43
with buffer containing 1% nonfat dry milk, exposed to 0.2 mg/mL
secondary antibody (Santa Cruz) bound to horseradish peroxidase,
incubated with ECL enhancer kit (Pierce) for 1 minute, and exposed
to x-ray film.
Preparation of HVJ-Liposomes
HVJ-liposomes were prepared according to Kaneda25 with minor
modifications. Briefly, 10 mg of lipids (phosphatidylcholine, choles-
terol, phosphatidylserine 4.8:2:1) were dissolved in 5 mL diethyl-
ether. Two hundred microliters of a 10 mmol/L solution of oligonu-
cleotides dissolved in BSS (137 mmol/L NaCl, 5.4 mmol/L KCl, and
200 mL Tris HCl [pH 7.0]) were injected, vortexed thoroughly, and
sonicated for 10 seconds in a bath-type sonicator. (The sequence of
the NF-kB oligonucleotide and the nonsense oligonucleotide were
identical to the sequences used in (EMSA), as described above.)
Thereafter, ether was removed using a rotary evaporator. From the
gel that formed under these conditions, liposomes were prepared by
vortexing. Liposomes were then fused with 30 000 hemagglutinating
units of UV-inactivated Sendai virus. All additional steps were
performed according to Kaneda.25 After dilution, 10 mL of HVJ-
liposomes carrying 5 mmol/L oligonucleotides were injected 10
minutes before ischemia and reperfusion.
Statistical Methods
The results are given as mean6SEM. Statistical analysis was
performed with 1-way ANOVA. Whenever a significant effect was
obtained with ANOVA, we performed multiple-comparison tests
between the groups using the Dunn test (Sigmastat statistical
program). Differences between groups were considered significant
for P,0.05.
Results
Hemodynamic and Contractile Effects of Ischemia
and Reperfusion
We first tested if our model of ischemia (15 minutes) and
reperfusion induces reperfusion injury, ie, myocardial and
endothelial stunning in isolated rat hearts. External heart
work and coronary flow were monitored in a preischemic
working phase (phase 1) and postischemically (phase 2). In
nonischemic hearts, external heart work in phase 2 (without
foregoing ischemia) was 95% of the external heart work in
phase 1 (Table). Coronary flow under fixed preload and
afterload (12 cm H2O and 80 mm Hg, respectively) was
identical in both periods. In contrast, hearts subjected to 15
minutes of ischemia and subsequent reperfusion displayed a
distinct loss of the capacity to perform external heart work,
recovery being 6866% of the preischemic value (myocardial
stunning). At the same time, coronary flow tended to decrease
during postischemic reperfusion.
Activation of Transcription Factors During
Early Reperfusion
Because we have shown previously that NF-kB is a crucial
transcription factor for posthypoxic ICAM-1 induction in a
cell culture model,26 we now investigated the activation
pattern of NF-kB in an isolated heart model displaying
“nonlethal” infringement of function during early reperfu-
sion. The activation was assessed by EMSA, relying on the
ability of activated NF-kB, which has dissociated from IkBa,
to bind to a specific double-stranded DNA sequence. As
shown in Figure 1A, NF-kB activation can be induced in
isolated hearts by TNF-a (100 pg/mL). NF-kB band retarda-
tion is inhibited by 100-fold excess competition with the
specific NF-kB oligonucleotide, but not with a nonspecific
(scrambled) oligonucleotide. (Both the specific and the
scrambled oligonucleotide are also used for HVJ-liposome
transfection; see Figure 4B.) No activation, however, is found
after ischemia (45 minutes). In contrast, the activated form of
NF-kB is present in the cytosol and translocated to the
nucleus as early as 30 minutes after ischemia (15 minutes)
and is detected up to 2 hours of reperfusion in the isolated rat
heart model (Figure 1B).
Antibody supershift experiments reveal that the NF-kB–
specific complexes detected comprise dimers of p65 and p50
(Figure 1C). A p50 antibody shifts 2 bands, the lower of
which is completely transposed. The upper of the shifted
Influence of Ischemia and Reperfusion on Myocardial Function
Group
Recovery,
%
CF1,
mL/min
CF2,
mL/min n
Control 9563 1061 1061 3
Ischemia and
reperfusion
6866* 1662 1462 6
Recovery is defined as postischemic/preischemic external heart
work3100%. CF1 indicates preischemic coronary flow; CF2, postischemic
coronary flow.
*P,0.05 vs control.
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bands is entirely deleted by a p65 antibody. We conclude that
both bands contain p50, the lower band as a homodimer, the
upper band as a p65/p50 heterodimer.
Parallel to the time course of NF-kB binding activity in the
nucleus, Western blot analysis detected p65 protein in nuclear
extracts as early as 30 minutes and up to 2 hours of
reperfusion (Figure 1D). Accordingly, nuclear translocation
of p65 coincides with a decrease in IkBa levels. The
reappearance of IkBa after 60 minutes of reperfusion has
been described by others and is itself an NF-kB–dependent
process.27 These experiments demonstrate that NF-kB is
activated and translocated to the nucleus not earlier than 30
minutes of reperfusion and remains activated for at least 2
hours.
Reperfusion Induces mRNA Specific for
Inflammatory Proteins
Because activation of NF-kB is involved in enhanced tran-
scription of several proinflammatory proteins such as
ICAM-1, we next investigated mRNA levels of ICAM-1
during postischemic reperfusion in our model. As shown in
Figure 2A, ICAM-1 mRNA is practically absent in normoxic
hearts (time-matched controls) but occurs in increasing
amounts from 60 minutes of reperfusion to a maximum of 2
hours postischemically, thereafter decreasing again. Inhibi-
tion of protein synthesis by addition of cycloheximide (CHX)
revealed that enhanced ICAM-1 mRNA expression is inde-
pendent of protein synthesis, suggesting that nuclear translo-
cation of transcription factors, which do not require protein
synthesis, is involved.
A similar pattern of postischemic gene induction was
found using probes for other proinflammatory proteins, such
as TNF-a and IL-1 (Figure 2C). Therefore, induction of
cytokines does not precede that of ICAM-1 in isolated
postischemic hearts, indicating that additional factors contrib-
ute to the NF-kB activation and ICAM-1 mRNA increase
after ischemia (see Figure 5).
ICAM-1 Induction Affects Postischemic PMN
Adhesion in Reperfused Hearts
Postischemic induction of ICAM-1 mRNA is accompanied
by increased translation of the protein (Figure 2B). To
investigate if enhanced ICAM-1 mRNA and protein levels
are correlated with a functional effect, we performed micro-
scopic evaluation of PMN adhesion in superficial coronary
vessels in a guinea pig model, which displayed an NF-kB
activation pattern similar to the rat heart (Figure 3A). The
protocol of the adhesion assay is displayed in Figure 3B.
Figure 1. A, EMSA of nuclear and cytosolic
extracts of isolated rat hearts demonstrates
NF-kB activation by TNF-a (100 pg/mL),
whereas ischemia (45 minutes) does not ac-
tivate NF-kB. Specific competition with 100-
fold excess of unlabeled oligonucleotide
encoding NF-kB binding site (s.) but not
unspecific competition (u.) with scrambled
oligonucleotide blocked NF-kB band retarda-
tion in the nuclear and cytosolic compart-
ment. B, EMSA time course of NF-kB activa-
tion after ischemia (15 minutes) and various
periods of reperfusion. NF-kB activation and
translocation to the nucleus is present from
30 minutes to 2 hours after ischemia. C,
Supershift EMSA experiment using p50 and
p65 antibodies (Santa Cruz) to identify
NF-kB–containing complexes. p50 antibody
shifts 2 of the demonstrated bands, whereas
the upper band disappears in the presence
of the deletional p65 antibody. Most likely,
the lower band represents p50 homodimers,
whereas the upper band contains p50/p65 dimers. D, Immunoblot of p65. Cytosolic (upper panel) and nuclear extracts (lower panel) of
the same hearts were used, demonstrating p65 translocation to the nucleus as soon as 30 minutes of reperfusion. Time course of cyto-
solic IkBa by Western blot. Results are representative for at least 3 separate experiments for each condition.
Figure 2. A, Time course of postischemic rat ICAM-1 mRNA
expression (upper panel) in comparison to GAPDH mRNA
expression (lower panel) by Northern blot. CHX 1 mmol/L was
added to exclude posttranscriptional modification at 2 hours of
reperfusion. B, Time course of postischemic rat ICAM-1 transla-
tion, detected by Western blot of whole cell extracts (300
mg/lane). C, Time course of cytokine induction, given as a ratio
of specific mRNA to GAPDH mRNA.
Kupatt et al March 5, 1999 395
 at Universitaetsbibliothek LMU on January 24, 2013http://circres.ahajournals.org/Downloaded from 
Double-fluorescence technique provided images of the vas-
cular bed (detected by FITC-dextran) as well as localization
of adherent PMN (prestained with rhodamine 6G).23 As
shown in Figure 3C for small coronary venules (10 to 50 mm
in diameter), PMN adhesion to an untreated, intact endothe-
lium is minimal (Control). However, injected at the onset of
reperfusion after ischemia, PMNs acutely adhere to an 8-fold
greater extent (Figure 3C, Acute I/R). Physiologically, PMN
adhesion declines progressively with duration of reperfusion
(data not shown). To ensure comparability of acute PMN
adhesion and PMN adhesion after 4 or 8 hours of reperfusion
(termed subacute PMN adhesion), PMNs were always in-
jected after a standard ischemia (15 minutes, 37°C). The
ischemic event was therefore the second one in the subacute
adhesion groups.
Interestingly, no further increase in adhesion could be seen
after 4 hours of reperfusion (4h R), compared with either
early acute postischemic PMN adhesion (0h R) or time-
matched controls (data not shown). In contrast, a significant
increase of postischemic PMN adhesion was found sub-
acutely after 8 hours of reperfusion (8h R) but not in
time-matched controls (data not shown).
To verify that ICAM-1 contributes to the subacute
postischemic increase of PMN adhesion, we incubated
PMN with an antibody against CD18, part of the leukocyte
b2 integrin ligands of ICAM-1 (guinea pig model, 10
minutes of incubation before bolus injection). Indeed, the
reperfusion-induced increase in PMN adhesion after 8
hours was specifically reduced by this intervention (8h
R1anti-CD18).
Role of NF-kB for Postischemic Induction of
Adhesion Molecules
Because the time courses of NF-kB activation, increase in
ICAM-1 mRNA, and enhanced ICAM-1–mediated PMN
adhesion suggested a causal relation of the 3 events, we
attempted to prevent the latter phenomena by inhibiting the
former. To investigate the role of NF-kB for postischemic
ICAM-1 induction during postischemic reperfusion, we used
transfection with decoy oligonucleotides containing a consen-
sus NF-kB binding site. As previously reported, decoy
oligonucleotides occupy the DNA binding domain of a
transcription factor, preventing binding of the corresponding
DNA sequence of promoters. Using HVJ-liposomes as vehi-
cles to incorporate fluorescence-labeled decoy NF-kB oligo-
nucleotides, we detected preferentially transfection of vessel
walls, whereas the parenchyma showed a sprinkled pattern of
partial transfection (Figure 4A). Moreover, cytosolic and
nuclear NF-kB binding activities were decreased more than
by scrambled oligonucleotides not binding NF-kB, even
though not entirely blocked (Figure 4B). Accordingly, post-
ischemic ICAM-1 mRNA transcription was reduced in the
presence of the NF-kB decoy oligonucleotide (Figure 4B). To
investigate the functional significance of the NF-kB activa-
tion for the subacute increment of postischemic PMN adhe-
sion, decoy transfection was also used in experiments assess-
ing subacute PMN adhesion. In those experiments, PMN
adhesion was reduced to the range of acute PMN adhesion, in
effect subtracting the subacute increase of postischemic PMN
adhesion (Figure 4C). In contrast, transfection with scram-
bled oligonucleotide had only a slight, insignificant effect on
Figure 3. A, EMSA demonstrating NF-kB
activation in the nuclear compartment of iso-
lated guinea pig hearts after 2 hours of reper-
fusion. Specific competition abolished the
retarded band, whereas p50 antibody incuba-
tion (2 mL) supershifted it. B, Protocol of PMN
adhesion assay during acute and subacute
reperfusion. A bolus 107 homologous PMN
was injected into the coronary system. After 3
minutes of washout, cardioplegic arrest and in
situ microscopy were performed. PMNs in
small venules (10 to 50 mm in diameter) of
isolated hearts are given as cell number/mm2
of vessel surface. C, Acute adhesion was
assessed directly after ischemia, whereas
subacute adhesion (4h R, 8h R, and 8h
R1anti-CD18) was assessed after 4 to 8
hours of reperfusion. *P,0.05 vs all other
groups; #P,0.05 vs Acute I/R and 8h R1anti-
CD18. Venules of 3 hearts were investigated
per time point; values are mean6SEM.
Figure 4. A, Three examples of hearts transfected with a carboxyfluorescein-labeled NF-kB decoy oligonucleotide (5 mmol/L) using
HVJ-liposomes. Preferentially, vessels are transfected (top). Parenchymal transfection is achieved to a certain degree, reflected by the
sprinkled fluorescence pattern (middle). Intracellularly, cytosol and nuclei are stained (right). No difference was found between normoxic
and postischemically reperfused hearts. B, EMSA of rat nuclear extracts of hearts exposed to ischemia and 2 hours of reperfusion (I/R)
without or with transfection of HVJ-liposomes containing decoy NF-kB oligonucleotide (Decoy, 5 mmol/L) or scrambled oligonucleotides
(Scr.oligo, 5 mmol/L). C, Northern blot of rat ICAM-1 mRNA demonstrating reduction of ICAM-1 mRNA level after transfection with
decoy NF-kB oligonucleotide. D, Guinea pig PMN adhesion immediately after ischemia (Acute I/R) in comparison to PMN adhesion
after 8 hours of reperfusion without (8h R) and with transfection with decoy NF-kB oligonucleotide (8h R1Decoy), which was imposed
at the beginning of the experiment. Transfection with scrambled oligonucleotides or mock transfections with unloaded liposomes
served as control (8h R1scrambled oligo and 8h R1Mock). *P,0.05 vs Acute I/R and 8h R1decoy. Figures demonstrate representa-
tive results of 3 independent experiments.
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subacute PMN adhesion, and mock transfection did not
influence PMN adhesion at all. These experiments demon-
strate a specific inhibition of NF-kB activation and down-
stream events of subacute endothelial activation by NF-kB
decoy transfection in postischemically reperfused hearts.
Influence of TNF-a on Induction of ICAM-1
Postischemic induction of genes might include the ones
encoding cytokines, subsequently leading to release of a class
of proteins that are well-known activators of the NF-kB
transcription factors. Therefore, we studied the time course of
postischemic cytokine induction during reperfusion of rat
hearts. Interestingly, TNF-a and IL-1 were induced by a
kinetic comparable to that of ICAM-1, although peaking
already after 1 hour of reperfusion (Figure 2B). Because
NF-kB activation already occurred as early as 30 minutes
after ischemia (Figure 1), cytokine induction may not account
for the initial postischemic NF-kB activation.
On the other hand, cleavage of cytokines from stored
precursor molecules might be a faster mechanism of cytokine
release. Figure 5A indicates that, in comparison to preische-
mic levels, a distinct rise of TNF-a was found in transudates
postischemically, reaching significant levels after 30 minutes
of reperfusion and disappearing after 2 hours. The time
course of IL-1 release was less pronounced and more re-
stricted to early reperfusion (data not shown). Therefore, we
investigated the possibility that the TNF-a found during early
reperfusion was causally associated with the binding activa-
tion of NF-kB. This result was further strengthened, because
TNF-a, exogenously added, was able to activate NF-kB
when applied for 60 minutes and washed out for 30 minutes
(Figure 1A), a regimen similar to the TNF-a release found in
postischemic transudates (Figure 5A).
As a second approach, endogenous TNF-a cleavage, most
likely the mechanism underlying early TNF-a release, was
prevented with BB 1101, an inhibitor of a hydroxamic acid
metalloproteinase specific for TNF-a. Figure 5 demonstrates
that BB 1101 actually inhibited all 3 events: postischemic
increase of TNF-a release of the isolated hearts (Figure 5A)
in concurrence with the postischemic activation of NF-kB
(Figure 5B) as well as ICAM-1 induction (Figure 5C).
Moreover, PMN adhesion after 8 hours of reperfusion and a
second ischemic trigger was reduced, almost to time-matched
control values (Figure 5D). Therefore, we were able to show
that subacute endothelial activation in postischemic hearts
can be antagonized by inhibition of TNF-a cleavage during
the first 4 hours of reperfusion.
Discussion
In the present study, we found that NF-kB activation after
ischemia leads to postischemically increased ICAM-1 mRNA
and protein levels and PMN adhesivity of the endothelial
lining, as demonstrated by an ex vivo PMN adhesion assay.
Observations of early TNF-a release as well as experiments
with a TNF-a cleavage inhibitor (BB 1101) suggest that
TNF-a liberation contributes to the postischemic NF-kB
activation and subsequent induction of the ICAM-1 gene.
Figure 6 displays a model for the underlying signaling
pathway. It was possible to block each of the given levels by
specific strategies: BB 1101 inhibited postischemic TNF-a
liberation and signaling, whereas transfection with decoy
oligonucleotides interrupted NF-kB translocation. Finally,
antibodies blocking the CD18-containing ligands of, for
example, ICAM-1 effectively suppressed subacutely en-
hanced PMN adhesion after ischemia.
PMN adhesion was performed in a guinea pig model,
providing long-term reperfusion of the heart without en-
hanced vascular permeability as well as highly purified,
Figure 5. A, Rat TNF-a concentrations of transudate after vari-
ous reperfusion intervals measured by ELISA. Five hearts were
followed up without treatment (black bars), whereas 3 hearts
(gray bars) received BB 1101, a TACE inhibitor. B, EMSA of
nuclear extracts of rat hearts without or with BB 1101 treatment.
C, Northern blot of ICAM-1 mRNA of rat hearts without or with
BB 1101 treatment. D, PMN adhesion assay (guinea pig), show-
ing that reduction of ischemia triggered PMN adhesion after BB
1101 treatment. Results of 3 independent experiments are
given.
Figure 6. Model of subacute endothelial activation. Postische-
mic TNF-a cleavage causes TNF-a release and subsequent
TNF-a–dependent activation of NF-kB. Thereafter, transcription
of ICAM-1 is enhanced, leading to formation of functional adhe-
sion molecules, as suggested by the PMN adhesion assay.
Because the process of ICAM-1 formation requires several
hours, it accounts for subacute reperfusion injury.
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modestly preactivated PMNs. Both features are prerequisites
for the double-fluorescence microscopy, in which extravasa-
tion of FITC-dextran would prevent visualization of the
vessel tree, and strong preactivation of PMNs would predis-
pose them to capillary plugging. Although the results of
subacute endothelial activation of the rat might not be
transferred to the guinea pig model without supporting data,
the activation pattern of NF-kB (Figure 3A) and the effects of
the CD18 antibody (Figure 3C), NF-kB decoy elements
(Figure 4D), and TACE inhibition (Figure 5C) underline the
presence of subacute endothelial activation in the given facets
in guinea pig hearts as well.
Taken together, these findings suggest that early cleavage
of TNF-a triggers a cascade of NF-kB activation and
ICAM-1 induction in response to postischemic reperfusion.
Similar processes have been observed in the fields of chronic
inflammation or transplantation medicine11 and have been
named subacute endothelial activation. The role of NF-kB for
ICAM-1 induction and enhanced PMN adhesion after ische-
mia was confirmed by liposome transfection with an NF-kB
decoy oligonucleotide (Figure 4C). The transfected decoy
oligonucleotide binds to the activated NF-kB, effectively
preventing its assembly at the corresponding sequence of
gene promoters that are regulated by this transcription fac-
tor,20 eg, ICAM-1. The experiments might extend understand-
ing of a previous study applying NF-kB decoy transfection to
prevent myocardial infarction in vivo in rats.28 In isolated
organs without blood-borne stimuli, we showed that postis-
chemic cardiac NF-kB activation enhances ICAM-1 expres-
sion and PMN adhesion, both closely related to infarct
size.1,13 Most interestingly, HVJ-liposomes containing decoy
elements easily reached the endothelial vessel lining but did
not transfect all parenchymal cells. Whether transfection of
the endothelium would suffice to reduce postischemic infarct
size in vivo is a question of considerable therapeutic impli-
cations that remains to be determined.
Other factors besides enhanced ICAM-1 expression on the
endothelial surface may have contributed to enhanced PMN
adhesion after prolonged reperfusion, especially induction of
P-selectin29 and E-selectin,30 adhesion molecules mediating
rolling as the first step of PMN adhesion. Given that in our
model PMN adhesion was inhibited by the nonselective
selectin antagonist Fucoidin, to about the same extent as by
the CD18 antibody (data not shown), we cannot rule out this
possibility. On the other hand, P-selectin is also acutely
upregulated by translocation from Weibel-Palade bodies,
becoming abundant on the cell surface rapidly, within min-
utes of stimulation,31 eg, after ischemia and reperfusion, as
used in our model. Moreover, subacute upregulation of
E-selectin during a general inflammatory response is not
essential for enhanced PMN rolling to occur,32 although it
modulates rolling velocities33 and leukocyte recruitment to
locally restricted stimuli.34 Whereas a protective role against
ischemia and reperfusion has not been described yet for
E-selectin– deficient organisms, protection is present in
ICAM-1–deficient mice, at least in kidney and brain.35,36
Therefore, although P-selectin and E-selectin induction might
have contributed to the subacute increase of PMN adhesion
after myocardial ischemia, the findings of the present study
and others accentuate the role of ICAM-1.
Which process is responsible for NF-kB activation during
early reperfusion? Previous studies have suggested new
cytokine synthesis as one possible cause.37 However, North-
ern blot analysis (Figure 2C) revealed that de novo synthesis
of cytokines cannot account for the NF-kB activation in our
experiments, because it occurs at least 30 minutes later.
Another process typically occurring during early reperfusion
is release of reactive oxygen species, which in cell culture,
using hypoxia and reoxygenation, suffices for NF-kB activa-
tion independently of receptor stimulation26 (and data not
shown). However, many different antioxidants (including
oxypurinol, uric acid, and glutathione) were unable to inhibit
NF-kB activation in the isolated heart (data not shown), at
least at dosages effectively blunting acute endothelial activa-
tion and PMN adhesion.38
In contrast, experiments with BB 1101, which affects
TNF-a cleavage by TACE,39,40 displayed inhibition of post-
ischemic NF-kB activation as well as of ICAM-1 induction
and acute endothelial activation and acute PMN adhesion
(Figure 5C). Although hydroxamic acid compounds like BB
1101 might interfere with other inflammatory proteins,41 IL-1
release was not affected by BB1101 (data not shown).
Moreover, exogenously applied TNF-a (at concentrations as
released in the transudate) mimicked the NF-kB activation
seen during postischemic reperfusion (Figure 1A). Therefore,
TNF-a cleavage by TACE may contribute to NF-kB–depen-
dent ICAM-1 induction during postischemic reperfusion. The
process stimulating TACE is not yet identified. However,
blockade of the L-type Ca21 channel by nifedipine, even at a
dosage severely affecting contractility, did not blunt it (data
not shown).
In summary, we describe a model for gene regulatory
response of the heart to the challenge of limited ischemia and
reperfusion. Enhanced transcription of, among others,
ICAM-1 is associated with an enhanced capacity to recruit
PMN at postcapillary coronary venules. The NF-kB activa-
tion found upstream of these events is, at least in part,
triggered by TNF-a stimulation. Further studies will be
conducted to elucidate the therapeutic potential of interfering
with subacute endothelial activation in the postischemically
reperfused heart.
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